These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6818354)

  • 1. X-ray conformational analysis of the potent thyroliberin analogue L-pyroglutamyl-beta-(2-thienyl)-L-analyl-L-prolinamide.
    Stensland B; Castensson S
    J Mol Biol; 1982 Oct; 161(2):257-68. PubMed ID: 6818354
    [No Abstract]   [Full Text] [Related]  

  • 2. Conformational properties of 2,3-methanopyroglutamic acid in peptides: NMR and x-ray diffraction studies.
    Mapelli C; Elrod LF; Switzer FL; Stammer CH; Holt EM
    Biopolymers; 1989 Jan; 28(1):123-8. PubMed ID: 2497811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton nuclear magnetic resonance studies of Nepsilon-Me-His2-thyroliberin. An hyperactive analogue of thyroliberin (thyrotropin-releasing factor).
    Bellocq AM; Dubien M
    Biochim Biophys Acta; 1976 Jan; 420(1):1-7. PubMed ID: 813772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroendocrine effect of thyroliberin and its analogs].
    Babichev VN; Samsonova VM; Airapetiants MG; Kolomeĭtseva IA; Shvachkin IuP
    Probl Endokrinol (Mosk); 1981; 27(4):35-8. PubMed ID: 6794024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational analysis of an analogue of thyroliberin (T.R.F.).
    Bellocq AM; Castensson S; Sievertsson H
    Biochem Biophys Res Commun; 1977 Jan; 74(2):577-83. PubMed ID: 402135
    [No Abstract]   [Full Text] [Related]  

  • 6. Global minimum energy conformations of thyrotropin releasing hormone analogs by simulated annealing. II.
    Garduño-Juárez R; Pérez-Neri F
    J Biomol Struct Dyn; 1991 Feb; 8(4):737-58. PubMed ID: 1905551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A thyrotropin-releasing hormone analogue: pGlu-Phe-D-Pro-psi [CN4]-NMe at 293 and 107 K.
    Howell PL; Pangborn WA; Marshall GR; Zabrocki J; Smith GD
    Acta Crystallogr C; 1995 Dec; 51 ( Pt 12)():2575-9. PubMed ID: 8588858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of a serum peptidase hydrolyzing thyroliberin at pyroglutamyl-histidine bone.
    Bauer K; Nowak P; Kleinkauf H
    Eur J Biochem; 1981 Aug; 118(1):173-6. PubMed ID: 6116600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroliberin (thyrotropin releasing hormone): antagonism of halothane and hexobarbital narcosis in mice. Comparison with pentetrazol, caffeine, d-amphetamine and adrenaline.
    Kruse H; Siegemund G; Rössner M
    Arzneimittelforschung; 1982; 32(3):211-3. PubMed ID: 6805483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational properties of central nervous system active thyrotropin releasing hormone analogues: probing structure-activity relationships at the molecular level.
    Eckle E; Stezowski JJ
    J Med Chem; 1985 Jan; 28(1):125-37. PubMed ID: 3917509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational analysis of NMR of an analogue of thyrotropin releasing factor: the tripeptide is less than Glu-Leu-Pro-A.
    Bellocq AM; Dubien M; Dupart E
    Biochem Biophys Res Commun; 1975 Aug; 65(4):1393-9. PubMed ID: 829894
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of the phosphinic analogue of thyrotropin releasing hormone.
    Matziari M; Bauer K; Dive V; Yiotakis A
    J Org Chem; 2008 Nov; 73(21):8591-3. PubMed ID: 18826326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
    Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y
    Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyroglutamyl-N3im-methyl-histidyl-prolineamide (methyl-thyrotrophin releasing hormone) in the rat hypothalamus.
    Pekary AE; Morley JE; Hershman JM
    J Endocrinol; 1978 Jun; 77(3):405-8. PubMed ID: 96203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice.
    Yamamoto M; Ozawa Y; Takeuchi H
    Arch Int Pharmacodyn Ther; 1993; 321():5-13. PubMed ID: 8100705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and spectroscopic investigation of Namide-ethylthyroliberin (author's transl)].
    Kalbacher H; König WA; Voelter W
    Hoppe Seylers Z Physiol Chem; 1975 Nov; 356(11):1827-9. PubMed ID: 812793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
    Browne P; O'Cuinn G
    Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational energy studies on N-methylated analogs of thyrotropin releasing hormone, enkephalin, and luteinizing hormone-releasing hormone.
    Manavalan P; Momany FA
    Biopolymers; 1980 Nov; 19(11):1943-73. PubMed ID: 6776998
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure of N-acetyl-L-leucyl-L-prolinamide monohydrate.
    Puliti R; Mattia CA; Lilley TH
    Acta Crystallogr C; 1992 Apr; 48 ( Pt 4)():709-12. PubMed ID: 1515104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.